Mitochondrial oxidant signalling in Alzheimer's disease

被引:0
|
作者
Vina, Jose [1 ]
Lloret, Ana [1 ]
Valles, Soraya L. [1 ]
Borras, Consuelo [1 ]
Badia, Mari-Carmen [1 ]
Pallardo, Federico V. [1 ]
Sastre, Juan [1 ]
Alonso, Maria-Dolores [1 ]
机构
[1] Fac Med, Dept Fisiol, Valencia 46010, Spain
关键词
apoptosis; gender; estrogenic compounds; antioxidants; MAP kinases;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The role of free radicals in Alzheimer disease pathophysiology has been appreciated for a long time. Originally, radicals were considered as causative of oxidative damage. More recently their role as signalling molecules in this, as well as in other fields of free radical biology, has been underscored. Mitochondria are both generators and targets of radical damage in aging. In this paper we review evidence that radicals generated in mitochondria in the presence of A beta are signals that trigger both the mitochondrial and the extra-mitochondrial pathways of apoptosis. There are gender specific differences in mitochondrial A beta toxicity: mitochondria from young (but not from old) females appear to be protected. 17-beta Estradiol or phytoestrogens like genistein prevent the formation of oxidants by mitochondria and protect against mitochondrial A beta toxicity. Experiments reported here indicate that phytoestrogens might have a role in the prevention of Alzheimer's disease.
引用
收藏
页码:175 / 181
页数:7
相关论文
共 50 条
  • [31] Alzheimer's disease: mutations, apoptosis and cellular signalling
    Vestling, M
    Cowburn, RF
    Winblad, B
    Ankarcrona, M
    CURRENT OPINION IN PSYCHIATRY, 2002, 15 (04) : 395 - 401
  • [32] Calcium dyshomeostasis and intracellular signalling in alzheimer's disease
    Frank M. LaFerla
    Nature Reviews Neuroscience, 2002, 3 : 862 - 872
  • [33] Molecular reorganization of endocannabinoid signalling in Alzheimer's disease
    Mulder, Jan
    Zilberter, Misha
    Pasquare, Susana J.
    Alpar, Alan
    Schulte, Gunnar
    Ferreira, Samira G.
    Koefalvi, Attila
    Martin-Moreno, Ana M.
    Keimpema, Erik
    Tanila, Heikki
    Watanabe, Masahiko
    Mackie, Ken
    Hortobagyi, Tibor
    de Ceballos, Maria L.
    Harkany, Tibor
    BRAIN, 2011, 134 : 1041 - 1060
  • [34] mTOR-dependent signalling in Alzheimer's disease
    Pei, Jin-Jing
    Hugon, Jacques
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2008, 12 (6B) : 2525 - 2532
  • [35] Oxidative signalling and inflammatory pathways in Alzheimer's disease
    Anderson, I
    Adinolfi, C
    Doctrow, S
    Huffman, K
    Joy, KA
    Malfroy, B
    Soden, P
    Rupniak, HT
    Barnes, JC
    NEURONAL SIGNAL TRANSDUCTION AND ALZHEIMER'S DISEASE, 2001, 67 : 141 - 149
  • [36] Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease
    LaFerla, FM
    NATURE REVIEWS NEUROSCIENCE, 2002, 3 (11) : 862 - 872
  • [37] Alzheimer's Disease: From Mitochondrial Perturbations to Mitochondrial Medicine
    Cardoso, Susana
    Carvalho, Cristina
    Correia, Sonia C.
    Seica, Raquel M.
    Moreira, Paula I.
    BRAIN PATHOLOGY, 2016, 26 (05) : 632 - 647
  • [38] Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease
    Onyango, Isaac
    Khan, Shaharyar
    Miller, Bradley
    Swerdlow, Russell
    Trimmer, Patricia
    Bennett, James, Jr.
    JOURNAL OF ALZHEIMERS DISEASE, 2006, 9 (02) : 183 - 193
  • [39] Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease
    Cadonic, Chris
    Sabbir, Mohammad Golam
    Albensi, Benedict C.
    MOLECULAR NEUROBIOLOGY, 2016, 53 (09) : 6078 - 6090
  • [40] Mitochondrial therapeutic interventions in Alzheimer's disease
    Giau, Vo Van
    An, Seong Soo A.
    Hulme, John P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 395 : 62 - 70